Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
678.00    -7.00 (-1.02%)
Bid:
665.00
Ask:
678.00
Spread: 13.00 (1.955%)
Market Cap: £658.48m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Interim Management Statement

23 Jan 2009 07:00

RNS Number : 1292M
Acal PLC
23 January 2009
 



FOR RELEASE

7.00 AM

23 JANUARY 2009

ACAL plc 

SECOND INTERIM MANAGEMENT STATEMENT

PERIOD COMMENCING 1 OCTOBER 2008

Acal plc is today issuing its second Interim Management Statement for the year ending 31 March 2009, which covers the period commencing 1 October 2008 to date and includes trading for the nine months ended 31 December 2008.

Current trading

As we have reported in earlier statements, our markets have become increasingly difficult over the last six months.

Although the Group's sales for the quarter ended 31 December 2008 were slightly ahead of the corresponding quarter to December 2007, margins within the Electronics Division were adversely impacted by the decline in sterling over the quarter.  Within the Supply Chain Division (formerly Parts Services), the new management team has commenced the integration of Service Source Europe and is working to resolve ongoing contract operating losses.

In light of current trading levels, one-off foreign exchange losses and the cost of implementing further efficiencies, the Group result for the year ending 31 March 2009 will be below market expectations.

Following the net benefit from the sale of MessageLabs Group and the acquisition of Service Source Europe Limited, the group retains significant net cash despite increasing pressures on working capital. 

With the appointment of Nick Jefferies as Group Chief Executive on 5 January 2009, we will be carrying out a comprehensive review of Acal's business and strategy. The Board remains confident in the opportunities for the development of the business.

The following material events or transactionseach of which has been previously reported, impacted the Group during the period covered by this Interim Management Statement.

MessageLabs Group Limited

The sale of MessageLabs Group Limited to Symantec was completed on 14 November 2008. The total consideration receivable by Acal for its 3.95% investment is £16.2 million of which £15.1 million was received on that date. The balance is retained in escrow and will be returned to Acal if there are no warranty claims within a 12 month period.

Service Source Europe Limited

The acquisition of 75% of Service Source Europe Limited (SSE) was completed on January 9 2009 for a consideration in cash of £1.85 million. In addition, Acal subscribed for deferred shares in SSE with a total nominal value of £346,625 in cash to enable SSE's preference shares to be redeemed.

  

For further information:-

Nicholas Jefferies ~ Chief Executive

Malcolm Cooper ~ Finance Director

Brian Coleman-Smith/James Verstringhe

Cubitt Consulting 

01483 544500

01483 544500

020 7367 5100

Notes to the Interim Management Statement

(a) This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Acal plc, as a body, in order to meet the requirements of the UK Listing Authority’s Disclosure and Transparency Rules.
 
(b) The Interim Management Statement may contain forward-looking statements which:

 

§ have been made by the directors in good faith based on the information available to them up to the time of their approval of this statement; and
 
§ should be treated with caution due to inherent uncertainties, which are beyond Acal’s ability to control or estimate precisely and include both economic and business risk factors, underlying such forward looking information.

Notes to Editors:

Acal is a leading European value-added distributor providing specialist design-in, sales and marketing services for international suppliers in the fields of Electronic Components, Supply Chain Services and Medical and Scientific products. Organised into three divisions, Acal has 15 principal trading companies of which 8 are in Continental Europe and 7 in the UK.

Acal is now Europe's strongest multi-disciplined design-in electronics distributor and has always differentiated its offering with a strong focus on demand creation and a highly skilled technical sales force. Vertec Scientific, which operates in both the UK and South Africa, represents leading manufacturers in the field of bone densitometry, medical imaging and diagnostics. The Supply Chain division provides spare parts to field services organisations and is a supplier to virtually every leading company in that market. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBCGDBXGDGGCD
Date   Source Headline
15th Mar 20187:00 amRNSNotice of Capital Markets Day
5th Mar 201810:26 amRNSDirector/PDMR Shareholding
21st Feb 20189:15 amRNSIssue of Equity
9th Feb 201812:11 pmRNSDirector/PDMR Shareholding
2nd Feb 20182:48 pmRNSTotal Voting Rights
1st Feb 20187:00 amRNSAcquisition
31st Jan 20187:00 amRNSTrading Update
23rd Jan 20187:00 amRNSDirectorate Change
29th Nov 20178:01 amRNSChange of Name
28th Nov 20179:06 amRNSHolding(s) in Company
28th Nov 20177:01 amRNSChange of Name
28th Nov 20177:00 amRNSHalf-year Report
16th Oct 20177:00 amRNSTrading Update
11th Oct 20175:25 pmRNSHolding(s) in Company
19th Sep 20175:04 pmRNSHolding(s) in Company
14th Sep 20177:00 amRNSSector Reclassification
13th Sep 201710:36 amRNSNotification of Change of Auditor
17th Aug 20172:33 pmRNSHolding(s) in Company
15th Aug 201711:32 amRNSDirector/PDMR Shareholding
4th Aug 201710:00 amRNSEXERCISE OF SHARE OPTION
3rd Aug 20174:30 pmRNSHolding(s) in Company
25th Jul 20173:47 pmRNSResult of AGM
25th Jul 20177:00 amRNSTrading Update
26th Jun 201710:38 amRNSAnnual Report and Accounts
21st Jun 20174:57 pmRNSHolding(s) in Company
13th Jun 201710:15 amRNSHolding(s) in Company
6th Jun 20177:00 amRNSFinal Results
19th Apr 20177:00 amRNSTrading Update
13th Apr 201712:34 pmRNSDirector/PDMR Shareholding
12th Apr 20178:50 amRNSHolding(s) in Company
4th Apr 20174:35 pmRNSHolding(s) in Company
29th Mar 20178:00 amRNSExercise of share option
22nd Mar 20174:42 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSAppointment of M&A Director
2nd Mar 20179:48 amRNSHolding(s) in Company
27th Feb 20178:51 amRNSHolding(s) in Company
6th Feb 20178:54 amRNSHolding(s) in Company
26th Jan 20174:10 pmRNSHolding(s) in Company
25th Jan 201710:57 amRNSDirector/PDMR Shareholding
24th Jan 20174:27 pmRNSHolding(s) in Company
20th Jan 20174:06 pmRNSResult of Placing
20th Jan 20177:01 amRNSAcquisition & Proposed Placing
20th Jan 20177:00 amRNSTrading Update
16th Jan 201710:27 amRNSHolding(s) in Company
14th Dec 201612:03 pmRNSHolding(s) in Company
5th Dec 20169:36 amRNSHolding(s) in Company
29th Nov 20167:01 amRNSAppointment of Chairman Designate
29th Nov 20167:00 amRNSHalf-year Report
18th Oct 201611:52 amRNSHolding(s) in Company
17th Oct 201611:39 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.